Green Cross remarkably grew up in first half of 2005.

Published: 2005-08-17 07:00:00

Updated: 2005-08-17 07:00:00

Green Cross reported 155,651 MW of sales during the first half of this year, 15.2 BW of operating income, 26,670 MW of ordinary income and 18.7 BW of net income, largely led by the sales of blood preparations at 70,354 MW and vaccines at 21,541 MW as well as OTC drugs like Zenol at 21,889 MW and ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK